Diese Präsentation wurde erfolgreich gemeldet.
Die SlideShare-Präsentation wird heruntergeladen. ×

Computer aided drug designing (CADD)

Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Wird geladen in …3
×

Hier ansehen

1 von 24 Anzeige

Computer aided drug designing (CADD)

Herunterladen, um offline zu lesen

CADD is a mixture of bioinformatics and computer science where the information from bioinformatics is combined into a software which makes it easier to process.

CADD is a mixture of bioinformatics and computer science where the information from bioinformatics is combined into a software which makes it easier to process.

Anzeige
Anzeige

Weitere Verwandte Inhalte

Diashows für Sie (20)

Ähnlich wie Computer aided drug designing (CADD) (20)

Anzeige

Aktuellste (20)

Computer aided drug designing (CADD)

  1. 1. Computer-Aided Drug Designing (CADD) Aakshay Subramaniam Aniketh Rao
  2. 2. Bioinformatics oAn application of Computer Science to biological and Drug Development science oBioinformatics is the field of science in which biology, computer science, and information technology merge to form a single discipline oThe ultimate goal of the field is to enable the discovery of new biological insights
  3. 3. Classification
  4. 4. Computer-Aided Drug Designing (CADD) oComputer-Aided Drug Designing (CADD) is a specialized discipline that uses computational methods to simulate drug-receptor interactions oCADD methods are heavily dependent on bioinformatics tools, applications and databases
  5. 5. R&D spending up, new drugs down
  6. 6. Drug Discovery & Development Identify disease Isolate protein involved in disease (2-5 years) Find a drug effective against disease protein (2-5 years) Preclinical testing (1-3 years) Formulation & Scale-up Human clinical trials (2-10 years) FDA approval (2-3 years)
  7. 7. Bioinformatics Supports CADD Research Virtual High-Throughput Screening (vHTS) Sequence Analysis Homology Modeling Similarity Searches Drug Lead Optimization Physicochemical Modeling Drug Bioavailability and Bioactivity
  8. 8. Virtual High-Throughput Screening (vHTS) oThe protein targets are screened against databases of small- molecule compounds oWith today’s computational resources, several million compounds can be screened in a few days on sufficiently large clustered computers oThis method provides a handful of promising leads e.g. ZINC is a good example of a vHTS compound library
  9. 9. Sequence Analysis oIt is very useful to determine how similar or dissimilar the organisms are based on gene or protein sequences oWith this information one can infer the evolutionary relationships of the organisms oThere are many bioinformatic sequence analysis tools that can be used to determine the level of sequence similarity e.g. DNA sequence analysis, gel electrophoresis
  10. 10. Homology Modeling oA common challenge in CADD research is determining the 3-D structure of proteins oThe 3-D structure for only a small fraction of the proteins is known oBioinformatics software tools are then used to predict the 3-D structure of the target based on the known 3-D structures of the templates oE.g. MODELLER SWISS-MODEL Repository
  11. 11. Similarity Searches o A common activity in biopharmaceutical companies is the search for drug analogues o Starting with a promising drug molecule, one can search for chemical compounds with similar structure or properties to a known compound o A variety of bioinformatic tools and search engines are available for this work
  12. 12. Benefits of CADD oThe Tufts Report suggests that the cost of drug discovery and development has reached $800 million for each drug successfully brought to market oMany biopharmaceutical companies now use computational methods and bioinformatics tools to reduce this cost burden
  13. 13. Benefits of CADD oVirtual screening, lead optimization and predictions of bioavailability and bioactivity can help guide experimental research oOnly the most promising experimental lines of inquiry can be followed and experimental dead-ends can be avoided early based on the results of CADD simulations
  14. 14. Benefits of CADD Time-to-Market: oCADD has predictive power oIt focuses drug research on specific lead candidates and avoids potential “dead-end” compounds
  15. 15. Benefits of CADD Insight: oCADD provides a deep insight to the drug-receptor interactions acquired by the researchers oMolecular models of drug compounds can reveal intricate, atomic scale binding properties that are difficult to envision in any other way
  16. 16. The Thalidomide Tragedy Structure of Thalidomide
  17. 17. Structure of Penicillin
  18. 18. Penicillin G Penicillin V NafcillinMethicillin
  19. 19. Identify disease Isolate protein Find drug Preclinical testing GENOMICS, PROTEOMICS & BIOPHARM. HIGH THROUGHPUT SCREENING MOLECULAR MODELING VIRTUAL SCREENING COMBINATORIAL CHEMISTRY IN-VITRO & IN-SILICO ADME MODELS Potentially producing many more targets and “personalized” targets Screening up to 100,000 compounds a day for activity against a target protein Using a computer to predict activity Rapidly producing vast numbers of compounds Computer graphics & models help improve activity Tissue and computer models begin to replace animal testing
  20. 20. CADD and bioinformatics together are a powerful combination in drug research and development.
  21. 21. Research Achievements oSoftware developed oBioinformatics database developed
  22. 22. Softwares developed oSVMProt: Protein function prediction software http://jing.cz3.nus.edu.sg/cgi-bin/svmprot.cgi oINVDOCK: Drug target prediction software oMoViES: Molecular vibrations evaluation server http://ang.cz3.nus.edu.sg/cgi-bin/prog/norm.pl
  23. 23. Bioinformatics databases developed oTherapeutic target database http://xin.cz3.nus.edu.sg/group/cjttd/ttd.asp o Drug adverse reaction target database http://xin.cz3.nus.edu.sg/group/drt/dart.asp o Drug ADME associated protein database http://xin.cz3.nus.edu.sg/group/admeap/admeap.asp o Kinetic data of bio molecular interactions database http://xin.cz3.nus.edu.sg/group/kdbi.asp oComputed ligand binding energy database http://xin.cz3.nus.edu.sg/group/CLiBE/CLiBE.asp

×